ENCISION INC — SEC Form D Filing

ENCISION INC filed an SEC Form D on September 17, 2026, reporting $80K raised in Medical Devices.

Form D filing details

Filing
SEC Form D
Filing date
September 17, 2026
Amount reported
$80K
Round stage
Series B+
Industry
Medical Devices
Website
https://www.encision.com/

What the company does

Securities: Equity. Revenue: $5,000,001 - $25,000,000. Exemption: Rule 506(b). Incorporated: COLORADO

Problem

During monopolar laparoscopic surgery, patients face a significant risk of unintended burns from intra-operative insulation failure and capacitive coupling, with these preventable stray energy burns occurring frequently and leading to patient deaths.

Solution

Encision provides AEM® Shield™ Laparoscopic Instruments and AEM enTouch® Reposable 2x Scissors which actively monitor and shield against insulation failure and capacitive coupling to eliminate these complications and improve patient safety during surgery.

Why now

Regulatory bodies like the FDA have issued safety communications on the dangers of monopolar laparoscopic surgery, and organizations like AORN have updated guidelines recommending AEM and shielding devices, creating a strong market demand for safer surgical instruments.

Verdict

This cleared because it offered a tangible solution to a regulated, high-stakes patient safety problem with existing guidelines creating immediate demand, not because it promised a disruptive shift in surgical practice. Investors were implicitly betting on rapid adoption within hospital systems driven by risk mitigation and regulatory compliance, where the cost of the device was minor compared to the cost of adverse events. The upside was limited by the specialized application within monopolar laparoscopic surgery and the strong incumbent presence requiring direct displacement rather than market expansion.

Source: SEC EDGAR Form D filing